{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:08:33Z","timestamp":1792375713637,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004567","name":"Government of the People's Republic of Bangladesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008627","name":"Global Affairs Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004441","name":"Swedish International Development Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jneuroim.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T20:47:26Z","timestamp":1497991646000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Tumor necrosis factor-alpha -863C\/A polymorphism is associated with Guillain\u2013Barr\u00e9 syndrome in Bangladesh"],"prefix":"10.1016","volume":"310","author":[{"given":"Israt","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijwan U.","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniz S.","family":"Farzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir M.","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad B.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad I.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-9199","authenticated-orcid":false,"given":"Yearul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quazi D.","family":"Mohmmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-8079","authenticated-orcid":false,"given":"Zhahirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.06.005_bb0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.gene.6364055","article-title":"Is there a future for TNF promoter polymorphisms?","volume":"5","author":"Bayley","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain\u2013Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0025","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","article-title":"The role of IL-12 and TNF-\u03b1 in AIDP and AMAN","volume":"15","author":"Deng","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2893.2006.00731.x","article-title":"Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population","volume":"13","author":"Du","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","article-title":"Genetic polymorphisms of macrophage-mediators in Guillain\u2013Barr\u00e9 syndrome","volume":"190","author":"Geleijns","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0040","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(92)90194-P","article-title":"Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve","volume":"108","author":"Jenkins","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0060","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s11033-011-0892-1","article-title":"Tumor necrosis factor alpha 308 G\/A polymorphism and Guillain-Barr\u00e9 syndrome risk","volume":"39","author":"Jiao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain\u2013Barr\u00e9 syndrome","volume":"258","author":"Lu, M.-O. & Zhu, J.","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","article-title":"Tumor necrosis factor\u2013\u03b1 polymorphisms and expression in Guillain\u2013Barr\u00e9 syndrome","volume":"71","author":"Prasad","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","article-title":"Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor","volume":"118","author":"Redford","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","article-title":"HLA-class II alleles in Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection","volume":"62","author":"Rees","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI113482","article-title":"Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes","volume":"81","author":"Sariban","year":"1988","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van Den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14728222.2017.1258402","article-title":"Tumor necrosis factor-\u03b1 in Guillain-Barr\u00e9 syndrome, friend or foe?","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2017.06.005_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","article-title":"Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome","volume":"58","author":"Zhang","year":"2007","journal-title":"Eur. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:38Z","timestamp":1759048178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817301029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"alternative-id":["S0165572817301029"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.06.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor necrosis factor-alpha -863C\/A polymorphism is associated with Guillain\u2013Barr\u00e9 syndrome in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}